158 related articles for article (PubMed ID: 32935851)
1. Nephronectin is a prognostic biomarker and promotes gastric cancer cell proliferation, migration and invasion.
Mei D; Zhao B; Zhang J; Xu H; Huang B
Histol Histopathol; 2020 Nov; 35(11):1263-1274. PubMed ID: 32935851
[TBL] [Abstract][Full Text] [Related]
2. Intracellular matrix Gla protein promotes tumor progression by activating JAK2/STAT5 signaling in gastric cancer.
Wang M; Chen L; Chen Y; Wei R; Guo Q; Zhu S; Guo S; Zhu S; Zhang S; Min L
Mol Oncol; 2020 May; 14(5):1045-1058. PubMed ID: 32086862
[TBL] [Abstract][Full Text] [Related]
3. Spondin 2 promotes the proliferation, migration and invasion of gastric cancer cells.
Lu H; Feng Y; Hu Y; Guo Y; Liu Y; Mao Q; Xue W
J Cell Mol Med; 2020 Jan; 24(1):98-113. PubMed ID: 31691494
[TBL] [Abstract][Full Text] [Related]
4. Circ_0009910 regulates growth and metastasis and is associated with poor prognosis in gastric cancer.
Liu M; Liu KD; Zhang L; Cai J; Yao HW; Bai YK; Zhang ZT
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8248-8256. PubMed ID: 30556864
[TBL] [Abstract][Full Text] [Related]
5. NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer.
Yu ZH; Wang YM; Jiang YZ; Ma SJ; Zhong Q; Wan YY; Wang XW
Pathol Res Pract; 2019 Oct; 215(10):152553. PubMed ID: 31362888
[TBL] [Abstract][Full Text] [Related]
6. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
Li J; Zou X
Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
[TBL] [Abstract][Full Text] [Related]
7. Elevated Orai1 and STIM1 expressions upregulate MACC1 expression to promote tumor cell proliferation, metabolism, migration, and invasion in human gastric cancer.
Xia J; Wang H; Huang H; Sun L; Dong S; Huang N; Shi M; Bin J; Liao Y; Liao W
Cancer Lett; 2016 Oct; 381(1):31-40. PubMed ID: 27431311
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen‑like‑protein 1 promotes the invasion and metastasis of gastric cancer and is associated with poor prognosis.
Zhang Y; Qiao HX; Zhou YT; Hong L; Chen JH
Mol Med Rep; 2018 Aug; 18(2):1465-1472. PubMed ID: 29845203
[TBL] [Abstract][Full Text] [Related]
9. TRIM14 promotes the migration and invasion of gastric cancer by regulating epithelial‑to‑mesenchymal transition via activation of AKT signaling regulated by miR‑195‑5p.
Wang F; Ruan L; Yang J; Zhao Q; Wei W
Oncol Rep; 2018 Dec; 40(6):3273-3284. PubMed ID: 30272351
[TBL] [Abstract][Full Text] [Related]
10. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of negative regulator of ubiquitin-like proteins 1 (NUB1) inhibits proliferation and invasion of gastric cancer cells through upregulation of p27Kip1 and inhibition of epithelial-mesenchymal transition.
Zhang D; Wu P; Zhang Z; An W; Zhang C; Pan S; Tan Y; Xu H
Pathol Res Pract; 2020 Aug; 216(8):153002. PubMed ID: 32703484
[TBL] [Abstract][Full Text] [Related]
12. Rab7 Is Associated with Poor Prognosis of Gastric Cancer and Promotes Proliferation, Invasion, and Migration of Gastric Cancer Cells.
Liu H; Xu J; Yao Q; Zhang Z; Guo Q; Lin J
Med Sci Monit; 2020 Jun; 26():e922217. PubMed ID: 32591494
[TBL] [Abstract][Full Text] [Related]
13. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
[TBL] [Abstract][Full Text] [Related]
14. Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression.
Pan L; Liang W; Fu M; Huang ZH; Li X; Zhang W; Zhang P; Qian H; Jiang PC; Xu WR; Zhang X
J Cancer Res Clin Oncol; 2017 Jun; 143(6):991-1004. PubMed ID: 28285404
[TBL] [Abstract][Full Text] [Related]
15. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
16. LRP4 promotes migration and invasion of gastric cancer under the regulation of microRNA-140-5p.
Mao Z; Wang Z; Zhang S; Pu Y; Wang J; Zhang T; Long Y; Liu Y; Ma Y; Zhu J
Cancer Biomark; 2020; 29(2):245-253. PubMed ID: 32675391
[TBL] [Abstract][Full Text] [Related]
17. MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1.
Liu L; Tian YC; Mao G; Zhang YG; Han L
Cell Signal; 2019 Oct; 62():109352. PubMed ID: 31260797
[TBL] [Abstract][Full Text] [Related]
18. Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.
Yuan C; Zhu X; Han Y; Song C; Liu C; Lu S; Zhang M; Yu F; Peng Z; Zhou C
J Exp Clin Cancer Res; 2016 Jan; 35():15. PubMed ID: 26791264
[TBL] [Abstract][Full Text] [Related]
19. LTBP2 promotes the migration and invasion of gastric cancer cells and predicts poor outcome of patients with gastric cancer.
Wang J; Liang WJ; Min GT; Wang HP; Chen W; Yao N
Int J Oncol; 2018 Jun; 52(6):1886-1898. PubMed ID: 29620158
[TBL] [Abstract][Full Text] [Related]
20. The role of microRNA-133b and its target gene FSCN1 in gastric cancer.
Guo L; Bai H; Zou D; Hong T; Liu J; Huang J; He P; Zhou Q; He J
J Exp Clin Cancer Res; 2014 Nov; 33(1):99. PubMed ID: 25433493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
